That will continue to drive collective, positive industry impact
However, stopping tirzepatide leads to predictable metabolic changes including weight regain and loss of glycemic control that require careful medical planning
We are grateful to the investigators, study participants, and partners who made this research possible, and remain committed to advancing scientific understanding and improving care for people living with IgA nephropathy
Research: The STEP trials assessed weight loss in people with obesity receiving a once-weekly injection of semaglutide (Wegovy) over 17 months (68 weeks)
I also liked being able to review the testing information before buying
Click here to learn more about the Semaglutide Meal Plan (Works with all GLP-1s) GLP-1 Weight Loss Series GLP-1s: Miracle, Mess, or Something In Between